| Literature DB >> 29892274 |
Sébastien Lambert1, Emmanuelle Gilot-Fromont1,2, Pauline Freycon2, Anne Thébault3, Yvette Game4, Carole Toïgo5, Elodie Petit6, Marie-Noëlle Barthe4, Gaël Reynaud4, Maryne Jaÿ7, Bruno Garin-Bastuji7, Claire Ponsart7, Jean Hars8, Sophie Rossi9.
Abstract
Wildlife reservoirs of infectious diseases raise major management issues. In Europe, brucellosis has been eradicated in domestic ruminants from most countries and wild ruminants have not been considered important reservoirs so far. However, a high prevalence of Brucella melitensis infection has been recently identified in a French population of Alpine ibex (Capra ibex), after the emergence of brucellosis was confirmed in a dairy cattle farm and two human cases. This situation raised the need to identify the factors driving the persistence of Brucella infection at high prevalence levels in this ibex population. In the present paper, we studied the shedding pattern of B. melitensis in ibex from Bargy Massif, French Alps. Bacteriological examinations (1-15 tissues/samples per individual) were performed on 88 seropositive, supposedly infected and euthanized individuals. Among them, 51 (58%) showed at least one positive culture, including 45 ibex with at least one Brucella isolation from a urogenital sample or a lymph node in the pelvic area (active infection in organs in the pelvic area). Among these 45 ibex, 26 (30% of the total number of necropsied animals) showed at least one positive culture for a urogenital organ and were considered as being at risk of shedding the bacteria at the time of capture. We observed significant heterogeneity between sex-and-age classes: seropositive females were most at risk to excrete Brucella before the age of 5 years, possibly corresponding to abortion during the first pregnancy following infection such as reported in the domestic ruminants. The high shedding potential observed in young females may have contributed to the self-sustained maintenance of infection in this population, whereas males are supposed to play a role of transmission between spatial units through venereal transmission during mating. This heterogeneity in the shedding potential of seropositive individuals should be considered in the future to better evaluate management scenarios in this system as well as in others.Entities:
Keywords: Alpine ibex (Capra ibex); Brucella melitensis; bacteriology; epidemiology; pathogenesis; serology; transmission; wildlife disease
Year: 2018 PMID: 29892274 PMCID: PMC5985404 DOI: 10.3389/fmicb.2018.01065
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Location of the study area in France and approximate localization of the five socio-spatial units identified in Marchand et al. (2017). These five socio-spatial units correspond to the best number of spatially-segregated groups as determined by hierarchical classification methods on distances between individuals measured as overlap between annual home ranges of GPS-collared female Alpine ibex. See Marchand et al. (2017) for details.
Definition of infection classes for Brucella melitensis in Alpine ibex, depending on bacteriological results on tissue samples of the three categories of organ (+: at least one positive culture, –: all cultures negative).
| Bacteriologically confirmed (active infection in any organ) | Active infection in organs in the pelvic area | Active infection in urogenital organs | + | ± | ± |
| – | + | ± | |||
| – | – | + | |||
| Bacteriologically unconfirmed | – | – | – | ||
Figure 2Distribution of the number of samples per individual, before and after the culling implemented in 2013 (A) and number of CFU per plate for males and females (B).
Number of bacterial cultures performed in Alpine ibex between October 2012 and June 2017 in search for Brucella melitensis, and number of positive cultures for each tissue sample of three categories of organs.
| Urogenital samples | Genital swab (in-the-field) | 6/36 (17%) | 5/23 (22%) |
| Genital tract | 9/41 (22%) | 5/11 (45%) | |
| Urine or bladder | 3/16 (19%) | 5/15 (33%) | |
| Testes | – | 12/32 (37%) | |
| Lymph nodes in the pelvic area | Supramammary lymph nodes | 17/48 (35%) | – |
| Inguinal lymph nodes | 1/1 | 6/19 (32%) | |
| Internal iliac lymph nodes | 18/50 (36%) | 12/29 (41%) | |
| Other organs | Retropharyngeal lymph nodes | 14/47 (30%) | 12/28 (43%) |
| Joints | 11/19 (58%) | 12/21 (57%) | |
| Abscesses | 6/6 | 3/4 | |
| Other organs | 14/57 (25%) | 2/13 (15%) | |
| Total | 99/321 (31%) | 74/195 (38%) |
One to15 samples were cultured per individual, leading to 516 bacteriological results from 88 animals. Percentages of positive cultures are indicated in brackets except when the sample size was <10.
Results of bacteriological detection of Brucella melitensis on three fetuses of Alpine ibex and their mothers in 2017.
| Fetuses | Heart | 4 | – | 0 | |
| Kidneys | 4 | 0 | 0 | ||
| Liver | 1 | 0 | 0 | ||
| Spleen | 4 | – | 0 | ||
| Abomasum | 4 | 0 | 0 | ||
| Testes | – | 0 | 0 | ||
| Total (positive/analyzed) | 5/5 | 0/4 | 0/6 | ||
| Mothers | Urogenital samples | Genital swab (in-the-field) | – | – | – |
| Genital tract | – | – | – | ||
| Urine or bladder | 4 | 0 | 0 | ||
| Lymph nodes in the pelvic area | Supramammary lymph nodes | 2 | 2 | 0 | |
| Inguinal lymph nodes | – | – | – | ||
| Internal iliac lymph nodes | 4 | 1 | 0 | ||
| Other organs | Retropharyngeal lymph nodes | 4 | 0 | 0 | |
| Joints | 0 | 0 | 0 | ||
| Abscesses | – | 2 (udder) | – | ||
| Spleen | 4 | 0 | 0 | ||
| Lungs | 4 | 0 | 0 | ||
| Cotyledons | 4 | 0 | 0 | ||
| Superficial cervical (prescapular) lymph nodes | 4 | – | 3 | ||
| Other | – | 0 | – | ||
| Total (positive/analyzed) | 8/9 | 3/10 | 1/9 | ||
0, negative bacterial culture; 1–4, positive bacterial culture (1: <10 CFU, 2: 10–50 CFU, 3: 50–100 CFU, 4: >100 CFU).
Distribution of infected Alpine ibex according to classes established from the category of organs positive for Brucella melitensis and to the number of positive samples per individual.
| Urogenital samples | 0 | 27 | 10 | 17 | 8 | 13 | 6 | 0 | 0 |
| 1 | – | – | 7 | 9 | 7 | 9 | 7 | 9 | |
| 2+ | – | – | 5 | 5 | 5 | 5 | 5 | 5 | |
| LN in the pelvic area | 0 | 27 | 10 | 6 | 9 | 2 | 7 | 2 | 7 |
| 1 | – | – | 10 | 8 | 10 | 8 | 4 | 4 | |
| 2+ | – | – | 13 | 5 | 13 | 5 | 6 | 3 | |
| Other organs | 0 | 27 | 10 | 7 | 7 | 7 | 7 | 4 | 3 |
| 1 | – | – | 13 | 7 | 10 | 5 | 2 | 5 | |
| 2+ | – | – | 9 | 8 | 8 | 8 | 6 | 6 | |
See Table .
Model selection table to analyze the probability of positive bacterial culture for any organ, for organs in the pelvic area, or for urogenital samples (random variables: ZONE and YEAR), and to analyze the number of CFU in each organ for females and for males (random variable: ID).
| − | |||||
| AGE + SEX × log(TITER) + AGE:log(TITER) | 8 | −154.05 | 326.1 | 0.73 | 0.136 |
| AGE + SEX × log(TITER) + AGE:log(TITER) + TREATMENT | 9 | −153.01 | 326.6 | 1.20 | 0.107 |
| AGE + SEX × log(TITER)+TREATMENT | 8 | −154.37 | 326.8 | 1.38 | 0.098 |
| AGE + SEX × log(TITER) + PERIOD | 8 | −154.61 | 327.2 | 1.84 | 0.078 |
| − | |||||
| AGE + SEX × log(TITER) + PERIOD | 8 | −112.27 | 242.6 | 1.71 | 0.115 |
| AGE + SEX × log(TITER) + AGE:log(TITER) | 8 | −112.37 | 242.8 | 1.90 | 0.105 |
| − | |||||
| AGE + SEX × log(TITER) + TREATMENT + PERIOD | 9 | −67.81 | 156.2 | 0.14 | 0.115 |
| AGE + SEX × log(TITER) + TREATMENT + AGE:SEX | 9 | −68.43 | 157.4 | 1.37 | 0.062 |
| AGE + SEX × log(TITER) + TREATMENT + PERIOD + AGE:SEX | 10 | −67.17 | 157.5 | 1.46 | 0.060 |
| AGE + SEX × log(TITER) + AGE:SEX | 8 | −70.00 | 158.0 | 1.98 | 0.046 |
| SEX × ORGAN + log(TITER) + SEX:log(TITER) + AGE | 11 | −477.79 | 978.2 | 0.00 | 0.071 |
| SEX × ORGAN + log(TITER) × AGE + SEX:log(TITER) | 12 | −476.93 | 978.5 | 0.38 | 0.058 |
| − | |||||
| SEX × ORGAN + log(TITER) + SEX:log(TITER) + AGE + AGE:SEX | 12 | −477.42 | 979.5 | 1.37 | 0.036 |
| SEX × ORGAN + log(TITER) + SEX:log(TITER) + AGE + PERIOD | 12 | −477.52 | 979.7 | 1.56 | 0.032 |
| SEX × ORGAN + log(TITER) × AGE+SEX:log(TITER) + PERIOD | 13 | −476.51 | 979.8 | 1.67 | 0.031 |
| SEX × ORGAN + log(TITER) + SEX:log(TITER) + AGE + TREATMENT | 12 | −477.65 | 980.0 | 1.82 | 0.028 |
| SEX × ORGAN + log(TITER) × AGE + SEX:log(TITER) + TREATMENT | 13 | −476.63 | 980.1 | 1.91 | 0.027 |
For each candidate model, the table gives the fixed variables (see text for definition), the number of Degrees of Freedom (DF), the Log-Likelihood (LL), the Akaike Information Criterion corrected for small sample size (AICc), ΔAICc<2 (Δ), and the Akaike Weight (W, see text for definition). The model selected is in bold.
Parameters of selected models to explain the probability of positive bacterial culture for any organ, for organs in the pelvic area, or for urogenital samples, and to explain the number of CFU in each organ.
| Probability of positive bacterial culture for any organ | AGE | 0.85 [0.77–0.93] | <0.001 |
| SEX (males) | 1.55 [0.97–2.47] | 0.066 | |
| log(TITER) | 2.71 [1.84–3.97] | <0.001 | |
| SEX:log(TITER) | 0.31 [0.19–0.49] | <0.001 | |
| Probability of positive bacterial culture for organs in the pelvic area | AGE | 0.84 [0.74–0.95] | 0.004 |
| SEX (males) | 1.49 [0.82–2.70] | 0.189 | |
| log(CFT) | 2.82 [1.70–4.67] | <0.001 | |
| SEX:log(TITER) | 0.27 [0.14–0.51] | <0.001 | |
| Probability of positive bacterial culture for urogenital samples | AGE | 0.80 [0.66–0.97] | 0.025 |
| SEX (males) | 1.62 [0.65–4.05] | 0.304 | |
| log(TITER) | 2.87 [1.30–6.30] | 0.009 | |
| SEX:log(TITER) | 0.21 [0.08–0.57] | 0.002 | |
| TREATMENT (fresh) | 3.24 [1.11–9.43] | 0.031 | |
| Number of CFU in each organ | SEX (males) | 3.69 [1.51–9.03] | 0.004 |
| ORGAN (NLpelvic) | 2.33 [1.32–4.11] | 0.004 | |
| ORGAN (others) | 2.65 [1.53–4.59] | <0.001 | |
| log(TITER) | 2.37 [1.43–3.94] | <0.001 | |
| SEX(males):ORGAN(NLpelvic) | 0.45 [0.20–1.00] | 0.050 | |
| SEX(males):ORGAN(others) | 0.33 [0.16–0.69] | 0.003 | |
| SEX:log(TITER) | 0.39 [0.19–0.80] | 0.010 |
The reference levels are females (for the variable SEX), frozen (for the variable TREATMENT), and urogenital (for the variable ORGAN).
Figure 3Predictions from the best models describing the relationship between age/sex (A,C,E, on the top) or complement fixation titers/sex (B,D,F, on the bottom) and the predicted probability for ibex of belonging to a specific class: bacteriologically confirmed (A,B, left: Brucella found in any organ), active infection in organs in the pelvic area (C,D, middle: Brucella found in urogenital samples and/or lymph nodes in the pelvic area), or active infection in urogenital organs (E,F, right: Brucella found in urogenital samples).
Figure 4Predictions from the model describing the number of CFU per plate for each organ in females (A) and in males (B) as a function of CFT titers and organ category.